World News
Novel Orexin Drug Normalizes Wakefulness in Narcolepsy Type 1

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — CHICAGO — Novel orexin receptor 2 agonist oveporexton normalized wakefulness for most people with narcolepsy type 1 in two randomized phase III trials.
Mean sleep latency across four, 40-minute Maintenance of Wakefulness…

:max_bytes(150000):strip_icc()/Health-GettyImages-1244861065-c20d53aa2b884b5ba9f7f68952645f5b.jpg?w=390&resize=390,220&ssl=1)

